{"timestamp": 1771602525.5790486, "value": {"ticker": "AVXL", "company_name": "Anavex Life Sciences Corp.", "short_name": "Anavex Life Sciences Corp.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 384587808, "float_shares": 89783179, "shares_outstanding": 92671758, "short_ratio": 12.47, "short_percent_of_float": 0.2241, "shares_short": 19953236, "shares_short_prior": 19650578, "insider_percent_held": 0.031170001, "institution_percent_held": 0.41541, "total_cash": 131749000, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 20.874, "book_value": 1.366, "price_to_book": 3.0380673, "operating_cashflow": -34075000, "free_cashflow": -21833624, "price": 4.15, "52w_high": 13.99, "52w_low": 2.86, "avg_volume": 2126786, "avg_volume_10d": 1569860, "full_time_employees": 34, "audit_risk": 6, "overall_risk": 3}}